Hanall Biopharma
KOSPI · Healthcare · ₩3T
₩50,100-4.75%
Price
51,300원
50,100원
Jun 15, 26Sep 11, 26
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
RevenueOperating IncomeNet Income
9/'26
Revenue₩44.8B+1.2%
Operating Income₩1.6B-71.4%
Net Income-₩300M+98.4%
6/'26 vs prev quarter
Company Health
Market Cap₩3T
Operating Margin+2.9%
Cash on Hand302억원1.1% of market cap
Free Cash Flow-54억원-0.2% of market cap
Short Volume 16.3% · as of 26.09.11
Among 98 제약 peers
LowMedianHigh
PSR17.4xmedian 0.8xPBR17.6xmedian 0.8xROE-15.4%median +4.9%
